Point72 Asset Management
NVO

Point72 Asset Management’s Novo Nordisk NVO Stock Holding History

Point72 Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.8M Buy
1,600,200
+1,281,900
+403% +$60.7M 0.08% 312
2025
Q4 		$16.2M Buy
+318,300
New +$16.3M 0.02% 1031
2025
Q1 		– Sell
-800,000
Closed -$68.8M – 2383
2024
Q4 		$68.8M Buy
+800,000
New +$86.5M 0.15% 152
2023
Q4 		– Sell
-880,000
Closed -$80M – 2612
2023
Q3 		$80M Buy
+880,000
New +$77.5M 0.23% 85

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Point72 Asset Management's NVO Position: Q3 2024 in Review

Point72 Asset Management sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 960,854 shares — an estimated $128M sold.

Point72 Asset Management first reported a position in NVO in Q4 2014 and held it in 10 quarters. The position peaked at $137M in Q2 2024. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Point72 Asset Management reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Point72 Asset Management sold 960,854 Novo Nordisk shares in Q3 2024, an estimated $128M.
  • Point72 Asset Management first reported a position in Novo Nordisk in Q4 2014 and held it in 10 quarters.
  • Point72 Asset Management's Novo Nordisk position peaked at $137M in Q2 2024.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.